Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEN-Study contraceptive effects on anticoagulation pathways
NL-OMON23980Active, not recruiting
- Start
- Jan 2005
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of avatrombopag, ethinyl estradiol, etonogestrel and norelgestromin (3 arms), sponsored by none. Primary endpoint: Activated protein C resistance. Started Jan 2005; status: active, not recruiting.
02
Drugs
avatrombopagethinyl estradioletonogestrelnorelgestromin
Beyond the preview
Go deeper on NL-OMON23980.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON23980.